Clinical trial
The Clinical Outcome and the Cost-effectiveness Analysis of Simvastatin Plus Standard Therapy Versus Standard Therapy Alone in Critically Ill Septic Patient"
NCT02067949 is registered in ClinicalTrials.gov with sara mostafa amin eladawy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Clinical Outcome and the Cost-effectiveness Analysis of Simvastatin Plus Standard Therapy Versus Standard Therapy Alone in Critically Ill Septic Patient"
- Lead sponsor
- sara mostafa amin eladawy
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- March 31, 2015
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.